Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25761571 | 0.96 | FAAH (0.54) | TSHRFAAHCYP1A2GAAMGAM | |
| SCHEMBL3007115 | 0.88 | TSHR (0.56) | TSHRFAAHGAAMGAMSI | |
| SCHEMBL15842189 | 0.88 | CYP1A2 (0.57) | TSHRFAAHCYP1A2GAAMGAM | |
| SCHEMBL18101453 | 0.87 | FAAH (0.60) | TSHRFAAHCYP1A2GAAMGAM | |
| SCHEMBL11484524 | 0.83 | FAAH (0.58) | TSHRFAAHCYP1A2GAAMGAM | |
| SCHEMBL1980139 | 0.83 | TSHR (0.71) | TSHRCYP1A2GAAMGAMSI | |
| SCHEMBL280333 | 0.83 | TSHR (0.71) | TSHRGAAMGAMSIMGAM2 | |
| Dimethyl Succinate SCHEMBL20529591 | 0.81 | TSHR (0.65) | TSHRCYP1A2GAAMGAMSI | |
| SCHEMBL10704882 | 0.81 | FAAH (0.69) | TSHRFAAHCYP1A2GAAMGAM | |
| SCHEMBL1300141 | 0.79 | FAAH (0.53) | TSHRFAAHALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203008-A1 | 3-AZABICYCLOALKYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | LG CHEM, LTD. (KR) | 2023-06-29 | — | — | US | disclosed |
| US-20230203008-A1 | 3-AZABICYCLOALKYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | LG CHEM, LTD. (KR) | 2023-06-29 | — | — | US | disclosed |
| US-20230203008-A1 | 3-AZABICYCLOALKYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | LG CHEM, LTD. (KR) | 2023-06-29 | — | — | US | disclosed |
| EP-4134366-A1 | 3-AZABICYCLOALKYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Lg Chem, Ltd. (KR) | 2023-02-15 | — | — | EP | disclosed |
| WO-2021215765-A1 | 3-AZABICYCLOALKYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 주식회사 엘지화학 (KR) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203008-A1 | 3-AZABICYCLOALKYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ADCY1, ADCY7 | TSHR 1706/4885FAAH 623/4885CYP1A2 69/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.